ATRI - Atrion Book Valuation of Business

ATRI (atrioncorp.com) - company brandmark

Atrion Corporation (ATRI) develops high-reliability gas and liquid infusion systems for ophthalmology and critical care, leveraging long-term OEM agreements. This price chart illustrates an asset where the indicator stands at 0.24. The business possesses pricing power due to patented components that are critical for its partners. Additional resilience is provided by the production of cardiology products and hospital care equipment, ensuring consistent demand.

ATRI Atrion Book Capitalization (07/04/2022 - 08/31/2024)

Atrion (ATRI) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Performance Chart Atrion Corporation Inc.|ATRI - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Atrion Corp.|ATRI - Total Company Value
- book capitalization data:
Accounting Value per Share Atrion|ATRI - Book Capitalization|Market-to-Book Ratio atrioncorp.com|ATRI - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Atrion Corporation|ATRI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Atrion Corp.|ATRI - Company Aggregate Debts|Debt to Book Value Atrion Corp.|ATRI - Company Long-Term Debts|Company Short-Term Debts Atrion
Fundamental valuation:ATRI - Atrion Corporation Inc.
Mass-produced product of Atrion Corp

Atrion Corporation (ATRI) ensures critical component precision for high-tech medical and industrial equipment, maintaining an impeccable status within its niche. An analysis of the cost of capital based on the balance sheet, reflecting the difference between net assets and liabilities, allows for the determination of the objective business value devoid of market speculation, helping investors avoid overpaying for inflated growth expectations.

Competitor analysis for Atrion Corporation

ISRG - Accounting Value of Company|Danaher Corp. - Book Capitalization|BDX (bd.com) - Book Valuation of Business|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value STAAR Surgical (STAA)|Company Book Value Chromadex Corp NAGE|Company Net Assets ZimVie Dental|Accounting Value of Company AngioDynamics Inc. ANGO|Book Capitalization CERS (Cerus Corporation)|TKNO: Book Valuation of Business|Company Book Value Monogram Orthopedics|STSS (Sharps Technology) - Accounting Capitalization|INFU: Company Book Value|Book Valuation of Business Utah Med (UTMD)|Company Net Assets KORU Medical Systems|Total Net Assets NYXH (nyxoah.com)|Company Book Value Microbot Medical|PDEX - Accounting Value of Company|Zentek Limited - Company Net Assets|ELUT: Book Capitalization|MLSS (Milestone Scientific) - Company Book Value|nexgel.com (NXGL) - Company Net Assets|Book Capitalization RVP (Retractable Technologies Inc.)|Total Stockholders' Equity HBIO|Company Book Value Femasys Corp FEMY|Accounting Capitalization meihuamed.com MHUA|Company Net Assets Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Total Net Assets|Company Book Value NURO (NeuroMetrix)